Back to Search
Start Over
PTC Therapeutics Completes Enrollment of Phase 3 Trial of Ataluren in Patients with Cystic Fibrosis
- Source :
- Clinical Trials Week. January 3, 2011, 39
- Publication Year :
- 2011
-
Abstract
- PTC Therapeutics, Inc. announced that it has completed enrollment of a Phase 3 clinical trial of ataluren, an investigational new drug, in patients with nonsense mutation cystic fibrosis (nmCF) (see [...]
Details
- Language :
- English
- ISSN :
- 15436772
- Database :
- Gale General OneFile
- Journal :
- Clinical Trials Week
- Publication Type :
- News
- Accession number :
- edsgcl.245588146